On-Demand Webinars
-
Decoding Biologic Performance: Combining SPR And Cell-Based Assays To Drive Development Decisions
11/5/2026
Binding affinity shows target engagement, but potency drives success. Combining biophysical and cell-based assays confirms activity, reduces risk, and speeds development.
-
Rethinking Facility Design For The Reality Of Complex Biologics
11/4/2026
Inert surface technologies reduce metal-related adsorption in chromatography, improving peak shape, recovery, sensitivity, and quantitation for more reliable analytical results.
-
Accelerating Late-Stage Biologics Through Platform-Based Manufacturing
11/3/2026
Prepare biologics for commercialization with strategies that improve process consistency, reduce manufacturing risk, and strengthen supply and capacity planning.
-
From iPSC Starting Material to Scalable GMP Manufacturing
11/2/2026
This webinar offers practical insight into reducing process-development complexity and creating a clearer path from product development to clinical production.
-
Process Development For CGT: How Soon Is Too Soon?
10/29/2026
Deciding when cell and gene therapy programs should commit to process development, and how early choices shape commercial readiness, is a question industry leaders examine from several different vantage points.
-
Pre-Developed Assays For Cell And Gene Therapies
10/29/2026
Pre-developed, fast-qualify assay libraries aim to expedite and harmonize analytical development for cell and gene therapies, offering a different route than building each assay from scratch.
-
Unlocking Hidden Efficiencies In Cell And Gene Therapy Manufacturing
10/28/2026
Identify hidden bottlenecks, cut batch variability, reduce costs, and protect quality. Learn strategies to streamline GMP transitions and speed commercialization.
-
Scaling Spray-dried Dispersions For Commercial Success: Scale, Capacity, Supply
10/26/2026
Scaling SDDs takes more than larger batches. Explore how early planning and process understanding can preserve performance and reduce commercialization risk.
-
Bioconjugation Scale-Up: Data-Driven Strategies From 10 L To 500 L
10/23/2026
Data-driven scale-up of ADC bioconjugation depends on matching mixing and temperature conditions. Solvent compatibility of single-use components and production-scale economics round out the decisions.
-
Plastic Components And Systems Used In Pharmaceutical Manufacturing
10/23/2026
Ensuring regulatory compliance for manufacturing components requires rigorous chemical characterization and risk-based testing to safeguard patient safety and product quality.